Articles by Rachel Grabenhofer, Chief Editor

contractors, engineers, supervise-GettyImages-1456699734
Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
Having previously explained why early-stage biotechs should avoid overbuilding, Alicia Collins, of Tune Therapeutics, continues the discussion here in part 2, with thoughts on scaling clinical supply, selecting partners, and preparing for future constraints.  Continue Reading..
Team collaboration, planning for property development-GettyImages-1796900872
The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
Early-stage biotechs often overbuild systems too soon. Alicia Collins explains why flexibility, simple processes, and realistic assumptions matter most.  Continue Reading..
GettyImages-2231025214 packaging
How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
From CAR-T to gene editing, clinical supply realities are increasingly influencing therapeutic design, scalability, and patient access.  Continue Reading..
Untitled design (3)
First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
Clinical Supply Leader unveils its first Editorial Advisory Board, featuring leaders across clinical supply, quality, regulatory affairs, technology, and strategy.  Continue Reading..
person walking by arrows-GettyImages-92347833
What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
Even strong plans fail without real-time alignment. As trials evolve, shared visibility, coordinated response, and early supply involvement keep execution on track.  Continue Reading..
cracked brick wall-GettyImages-1449964933
What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
Even strong plans fail without real-time alignment. As trials evolve, shared visibility, coordinated response, and early supply involvement keep execution on track.  Continue Reading..
Boardroom lunch meeting-GettyImages-2229997928
What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
Late involvement turns small gaps into costly problems. Bringing clinical supply in early improves planning, communication, and prevents downstream issues.  Continue Reading..
Group of doctors in meeting-GettyImages-2169868459
From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
Clinical supply leaders bring resilience, adaptability, and judgment; integrating their expertise early in planning strengthens trial execution and strategic decision-making.  Continue Reading..
Virtual Flowchart-GettyImages-1223164458
Invisible Yet Accountable: How Clinical Supply Pressures Build Strategic Leaders
Clinical supply leaders operate under unseen pressure, balancing risk, uncertainty, and tradeoffs — building strategic judgment that drives trial success.  Continue Reading..
Team planning strategies-GettyImages-1158389148
Decision Authority And Direction — The Gap In Deviation Planning
Faster excursion detection improves supply visibility but also exposes an often-overlooked gap: a deviation plan outlining who has authority and what actions to take.  Continue Reading..

RACHEL GRABENHOFER

RachelRachel Grabenhofer is the Chief Editor and community ambassador for Clinical Supply Leader. Her ambition is to uncover solutions to the unique challenges faced by professionals specializing in clinical supply for pharma R&D.

She achieves such by engaging leading experts and organizations dedicated to this niche space, expressing their insights through interviews, thought leadership pieces, multimedia content – including panel discussions, videos, podcasts – and more.

Rachel’s curiosity and love for science have guided her path to clinical supply. She brings 25 years of editorial experience in trade media focused on ingredient chemistry, skin physiology, pharmacological dynamics, toxicology and regulatory constraints for cosmetics and personal care product development. 

She built a global following as the Managing Scientific Editor of Cosmetics & Toiletries – a role that carried her around the world to give podium presentations, moderate panel discussions, serve as awards juror, chair conferences, visit cosmetic R&D labs and manufacturing facilities, and more.

Most recently, she presented on integrating biotechnology into beauty during the April 2025 In-Cosmetics Global trade show in Amsterdam. She also judged the 2026 Cosmetics Victories competition for Cosmetics360 in Paris.

In her downtime, Rachel enjoys yoga, hiking and tending to her tomatoes. She’s an avid enthusiast of her son’s bowling and swimming, and an unwavering Chicago Bears fan. She is also a passionate advocate for autism awareness.

Connect on LinkedIn